A series of recent developments is highlighting a pattern: Pharmacy is facing overlapping pressure from drug pricing, supply instability and policy changes. Over the past month, some of the most significant pharmacy moves have centered on rising drug costs, growing…

The FDA has alerted healthcare providers and patients about an increased risk of new blood cancers tied to Tazverik (tazemetostat) and said the drug’s sponsor plans to withdraw the product from the U.S. market. Tazverik was approved under the FDA’s…

Paterson, N.J.-based St. Joseph’s Health has named Susan Jacob, PharmD, system director of pharmacy, according to a LinkedIn post. Dr. Jacob most recently served as assistant director of clinical pharmacy services at NYC Health + Hospitals from June 2024 through…

Lentocilin, a penicillin G benzathine product, is back in stock and available to hospitals, clinics and pharmacies nationwide on Cost Plus Drugs’ marketplace. The restock comes as healthcare organizations continue managing supply disruptions affecting penicillin G benzathine products across the…

Drugmakers are navigating regulatory shifts, trial setbacks and major dealmaking as the FDA advances new models for drug development and political pressure reshapes the approval process. Here are five recent moves to know:

Optum Rx, UnitedHealth Group’s pharmacy benefit manager, said it will roll out a fee-based structure to customers in the coming years. A May 11 news release from Optum said Optum Rx’s agreements have traditionally been linked to drug prices or…

A personalized vaccine for patients with glioblastoma produced a safe and effective immune response, according to a study published May 12 in Nature Cancer.  A phase 1 clinical trial of the vaccine was conducted at St. Louis-based Siteman Cancer Center…

The FDA is seeking public input on drug repurposing efforts aimed at expanding treatment options for diseases tied to unmet medical needs. The agency said identifying new uses for FDA-approved drugs could accelerate treatment availability by relying on existing safety…

Use of manufacturer-sponsored coupons for brand-name drugs declined among commercially insured patients between 2017 and 2024, even as the value of coupon offsets increased, according to a study published April 6 in JAMA. The study analyzed pharmacy claims data from…

Hospital pharmacy has quietly become one of healthcare’s most data-intensive divisions. Pharmacy teams analyze controlled substance movement to detect drug diversion, optimize drug spending, monitor shortages to plan purchasing and clinical strategies, and ensure that every high-cost drug in decentralized…